Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

西格列汀二甲双胍缓释片 - NMPA Drug Approval Details

Approvals/NMPA/Sitagliptin Phosphate and Metformin Hydrochloride Sustained-release Tablets

Approved

化学药品

Sitagliptin Phosphate and Metformin Hydrochloride Sustained-release Tablets

广东东阳光药业股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 16, 2025
Approval ID: 8pdYoyfOCWx
Company: 广东东阳光药业股份有限公司
Type: 化学药品

Approval Details

Approval Id: 8pdYoyfOCWx
Approval Number: 国药准字H20256238
Generic Name: 西格列汀二甲双胍缓释片
Generic Name En: Sitagliptin Phosphate and Metformin Hydrochloride Sustained-release Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 磷酸西格列汀100mg（按C₁₆H₁₅F₆N₅O计）和盐酸二甲双胍1000mg
Reg Date: 2025-12-16
Company Name: 广东东阳光药业股份有限公司
Company Address: 广东省东莞市松山湖园区工业北路1号
Production Company Name: 宜昌东阳光长江药业股份有限公司
Production Company Address: 湖北省宜昌宜都市滨江路38 号
Company Detail Path: /organization/f691c17cb0ae2d64/yan-dong-dong-yang-guang-yao-ye-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/ff75da8cf2076f04/hec-cj-pharm

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 16, 2025

Approval ID

8pdYoyfOCWx

Type

化学药品

Back to NMPA Approvals